Avid Bioservices announced the grand opening of its new Early Phase Center of Excellence, a state-of-the-art 78,000 square foot facility located in Costa Mesa, California. Purpose built to support early clinical programs, the new center expands Avid's development footprint and strengthens the company's ability to provide end-to-end services from cell line development through commercial manufacturing.
Designed to accelerate clients' early development timelines, the facility brings together Avid's core scientific and technical capabilities including:
- Cell line development
- Upstream and downstream process and analytical development
- IND enabling analytical method qualification, and testing
- Early formulation development and characterization
- Integrated tech transfer into Avid's CGMP manufacturing facilities
The Early Phase Center of Excellence was purpose-built to further accentuate Avid's capabilities, to streamline early development activities, and enable a seamless transition into full scale CGMP operations. The center houses experienced, hands on scientific and manufacturing teams, established platform processes, and harmonized quality systems aligned with Avid's commercial manufacturing facility. This alignment ensures consistency, eliminates rework, and provides a smooth progression as programs advance from preclinical through to commercial supply.
"Our new Early-Phase Center of Excellence is purpose-built to help both established pharma and innovative biotech companies move into the clinic faster - in a predictable way, with quality and stability as the foundation. Our mission is to strengthen early drug development here in the U.S., accelerating the journey from scientific discovery to patient impact." said Kenneth Bilenberg, Chief Executive Officer of Avid Bioservices. "The industry has been asking for a U.S.-based development and manufacturing powerhouse that combines speed, quality, and scientific rigor and we built it."